THYROID GLAND INJURY

THYROID GLAND INJURY was reported 50 times

THYROID GLAND INJURY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] 8 0.0003
1 Programmed Death Receptor-1 Blocking Antibody [EPC] 18 0.0002
2 Provitamin D2 Compound [EPC] 4 0.0001
3 Glinide [EPC] 1 0.0001
4 Orexin Receptor Antagonist [EPC] 1 0.0001
5 CD52-directed Cytolytic Antibody [EPC] 1 0.0001
6 Vitamin C [EPC] 9 0.0000
7 CTLA-4-directed Blocking Antibody [EPC] 1 0.0000
8 Microtubule Inhibitor [EPC] 3 0.0000
9 Aromatase Inhibitor [EPC] 2 0.0000
10 Methylxanthine [EPC] 1 0.0000
11 Proton Pump Inhibitor [EPC] 9 0.0000
12 Central Nervous System Stimulant [EPC] 1 0.0000
13 Dietary Cholesterol Absorption Inhibitor [EPC] 1 0.0000
14 Kinase Inhibitor [EPC] 6 0.0000
15 Acetylcholine Release Inhibitor [EPC] 1 0.0000
16 Sulfonylurea [EPC] 1 0.0000
17 Angiotensin Converting Enzyme Inhibitor [EPC] 1 0.0000
18 Factor Xa Inhibitor [EPC] 2 0.0000
19 Calcium [EPC] 1 0.0000
20 Janus Kinase Inhibitor [EPC] 1 0.0000
21 Vitamin B12 [EPC] 2 0.0000
22 Nonsteroidal Anti-inflammatory Drug [EPC] 8 0.0000
23 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
24 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
25 Interferon beta [EPC] 1 0.0000
26 Mood Stabilizer [EPC] 1 0.0000
27 Insulin Analog [EPC] 2 0.0000
28 Loop Diuretic [EPC] 2 0.0000
29 Alkylating Drug [EPC] 1 0.0000
30 Platinum-based Drug [EPC] 1 0.0000
31 Osmotic Laxative [EPC] 1 0.0000
32 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
33 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
34 GLP-1 Receptor Agonist [EPC] 1 0.0000
35 Atypical Antipsychotic [EPC] 1 0.0000
36 Thalidomide Analog [EPC] 1 0.0000
37 Platelet Aggregation Inhibitor [EPC] 1 0.0000
38 Benzodiazepine [EPC] 1 0.0000
39 Corticosteroid [EPC] 1 0.0000